Gen Digital Inc. engages in the provision of cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers security and performance products under Norton, Avast, Avira, AVG, and CCleaner brands that provide real-time protection and maintenance for PCs, Macs, and mobile devices against malware, viruses, adware, and other online threats. It also provides identity protection solutions, including LifeLock Identity Theft Protection, Avast and AVG Secure Identity, Norton Identity Theft Protection, and Dark Web Monitoring for monitoring of credit reports, financial accounts, the dark web, and social media accounts to help safeguard customers' personal information. In addition, the company offers Virtual Private Network (VPN) solutions under Norton, Avast and AVG brands to enhance security and online privacy that allows customers to securely transmit and access private information, such as passwords, bank details, and credit card numbers, when using public Wi-Fi on PCs, Macs, and mobile iOS and Android devices; AntiTrack and Secure Browser products which helps to keep personal information and browsing activity anonymous while browsing online; and Privacy Monitor Assistant and BreachGuard products for removing customers' data from public data broker sites; and ReputationDefender, a white glove service that helps customers manage all aspects of their personal branding online, including search results, social media sites, and overall web presence. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Gen Digital Inc.

Qiagen ( ($QGEN) ) has provided an update. Qiagen disclosed that the Netherlands Authority for the Financial Markets notified the company of a subs...

Bank of America Reveals 3.01% Indirect Stake in Qiagen

The latest update is out from Qiagen ( ($QGEN) ). Qiagen has disclosed a notification from the Dutch Authority for the Financial Markets indicating...

Goldman Sachs Reports 2.87% Stake in Qiagen via Equity and Derivatives

ARK’s daily trade report for June 17 showed Cathie Wood moving capital across several high-profile names. The firm trimmed positions in Robinhood M...

LLY, COIN, HOOD, and ROKU Stocks in Focus: Cathie Wood Sells Winners and Buys New Catalysts — 6/18/26

General Capital Ltd. ( ($NZ:GEN) ) just unveiled an update. General Capital Limited has set the strike price for its Dividend Reinvestment Plan at ...

General Capital Sets NZ$0.261 Strike Price for Dividend Reinvestment Plan

The latest announcement is out from Gencor ( ($GENC) ). On May 19, 2026, Gencor Industries, Inc. disclosed it had received a delinquency notificati...

Gencor Regains NYSE Compliance After Delayed Quarterly Filing

An announcement from Qiagen ( ($QGEN) ) is now available. Qiagen has reported that the Dutch financial regulator AFM notified the company of a subs...

Goldman Sachs Discloses 3.03% Voting Interest in Qiagen

The latest update is out from Qiagen ( ($QGEN) ). Qiagen disclosed that the Dutch financial regulator AFM has published a voting rights notificatio...

Goldman Sachs Reports 2.72% Voting Stake in Qiagen via AFM Filing

An announcement from Qiagen ( ($QGEN) ) is now available. Qiagen disclosed that the Dutch financial markets regulator AFM has published a notificat...

Goldman Sachs Discloses 3.78% Voting Interest in Qiagen via AFM Filing

An announcement from Legal & General ( ($GB:LGEN) ) is now available. Legal & General Group has repurchased 3,821,565 ordinary shares between 8 and...

Legal & General Cancels 3.8 Million Shares in Ongoing Buyback

An update from Qiagen ( ($QGEN) ) is now available. Qiagen disclosed that Norway’s central bank, Norges Bank, has notified the Dutch financial mark...

Norges Bank Discloses 2.59% Stake in Qiagen

Qiagen ( ($QGEN) ) has issued an announcement. Qiagen reported that the Dutch financial markets regulator AFM disclosed a voting rights notificatio...

Goldman Sachs disclosed as 2.82% shareholder in Qiagen via AFM filing

Qiagen ( ($QGEN) ) has provided an update. Qiagen reported that the Dutch financial regulator AFM has disclosed a notification concerning voting ri...

Norges Bank Discloses 3.23% Voting Stake in Qiagen

Agenus Inc. ($AGEN) announced an update on their ongoing clinical study. The Phase II study “A Randomized, Open-Label, Phase II Trial of Nab-paclit...

Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion

There’s a lot to be optimistic about in the Communication Services sector as 3 analysts just weighed in on Genius Sports Limited (GENI), Magnite (M...

Analysts Offer Insights on Communication Services Companies: Genius Sports Limited (GENI), Magnite (MGNI) and Anterix (ATEX)

H.C. Wainwright analyst Ram Selvaraju maintained a Buy rating on NervGen Pharma on June 8 and set a price target of $18.00. Selvaraju covers the He...

H.C. Wainwright Reaffirms Their Buy Rating on NervGen Pharma (NGEN)

Qiagen ( ($QGEN) ) has issued an announcement. Qiagen disclosed that the Dutch financial regulator AFM has notified the company of a substantial sh...

Goldman Sachs reports 2.52% stake in Qiagen via AFM filing

Qiagen ( ($QGEN) ) has shared an update. QIAGEN has disclosed that the Dutch financial regulator AFM informed the company of a new substantial shar...

Goldman Sachs Reports 3.24% Indirect Stake in QIAGEN via AFM Filing

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General Group Plc reported that several senior executives, including the Group...

Legal & General Executives Reinvest Dividends in Company Shares

Legal & General ( ($GB:LGEN) ) has issued an announcement. Legal & General has repurchased 6,188,720 ordinary shares between 1 June and 5 June 2026...

Legal & General Cancels Over 6.1 Million Shares in Ongoing Buyback

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General has disclosed that several directors and senior executives acquired or...

Legal & General Directors Increase Holdings via Dividend Reinvestment Plan

GENinCode UK Ltd. ( ($GB:GENI) ) has shared an announcement. GENinCode reported a 14% rise in 2025 revenues to £3.1m, driven by volume growth in th...

GENinCode targets accelerated genetic testing scale-up as revenues rise and U.S. adoption grows

Morgan Stanley analyst Hadley Cohen maintained a Hold rating on Legal & General yesterday and set a price target of p240.00. According to TipRanks,...

Morgan Stanley Keeps Their Hold Rating on Legal & General (LGEN)

Gencor ( ($GENC) ) has shared an announcement. On June 1, 2026, Gencor Industries appointed Raymond Cole as interim chief financial officer under a...

Gencor Names Raymond Cole Interim Chief Financial Officer

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Compugen, with a price target of $4.00. Ramakant...

H.C. Wainwright Keeps Their Buy Rating on Compugen (CGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines ...

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC)

The latest update is out from GEN Restaurant Group, Inc. Class A ( ($GENK) ). GEN Restaurant Group has implemented a planned finance leadership tra...

GEN Restaurant Group Announces CFO Transition and Expansion Focus

An update from Legal & General ( ($GB:LGEN) ) is now available. Legal & General has disclosed that several senior executives, including the group c...

Legal & General Executives Buy Shares Under Employee Plan

Legal & General ( ($GB:LGEN) ) has provided an update. Legal & General has disclosed a transaction by its Group Chief Risk Officer, Chris Knight, u...

Legal & General Discloses Share Option Exercise by Chief Risk Officer

Genuit Group ( ($GB:GEN) ) has provided an update. Genuit Group plc disclosed that non-executive director and person discharging managerial respons...

Genuit Non-Executive Director Increases Stake with £31,480 Share Purchase

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Qiagen (QGEN) and Unicycive Therapeutics (UNCY) with...

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Unicycive Therapeutics (UNCY)

Genmin Ltd. ( ($AU:GEN) ) just unveiled an announcement. Genmin non-executive director John Hodder has increased his indirect shareholding in the c...

Genmin Director John Hodder Lifts Indirect Shareholding via On-Market Purchase

Gencor ( ($GENC) ) just unveiled an update. On May 19, 2026, Gencor Industries Inc. received a delinquency notification from NYSE Regulation after ...

Gencor Faces NYSE Noncompliance After Missed Quarterly Filing

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General has disclosed a share transaction by non-executive director Mar...

Legal & General discloses share purchase by non-executive director

Legal & General ( ($GB:LGEN) ) has shared an update. Legal & General Group has repurchased 5,493,017 of its ordinary shares between 27 and 29 May 2...

Legal & General Cancels 5.5m Shares in Ongoing Buyback Drive

Legal & General ( ($GB:LGEN) ) just unveiled an update. Legal & General has confirmed that, as of 29 May 2026, its share capital comprised 5,558,65...

Legal & General Updates Share Capital and Voting Rights After Buyback

Legal & General ( ($GB:LGEN) ) just unveiled an update. Legal & General has admitted 118,837 new ordinary shares of £0.025 each to trading on the M...

Legal & General Adds Sharesave Scheme Stock to London Listing

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK) and Qiagen (QGEN) with bullish...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Qiagen (QGEN)

An announcement from Genuit Group ( ($GB:GEN) ) is now available. Genuit Group has disclosed share purchases by two senior insiders, in line with U...

Genuit executives increase personal stakes with share purchases

NervGen Pharma ( ($NGEN) ) has provided an update. On May 26, 2026, NervGen Pharma reported independently conducted, blinded biomechanical gait ana...

NervGen Reports Objective Neural Recovery Signal for NVG-291 in Chronic SCI Ahead of Phase 3

Qiagen ( ($QGEN) ) has provided an update. QIAGEN disclosed that the Dutch financial regulator AFM has notified the company of a substantial shareh...

Norges Bank Discloses 2.44% Stake in QIAGEN

Legal & General ( ($GB:LGEN) ) has shared an announcement. Legal & General Group has repurchased 12,578,843 ordinary shares between 18 and 22 May 2...

Legal & General Cancels 12.6 Million Shares Under Ongoing Buyback

FTSE Russell has released its preliminary changes for the Russell 3000 Index ahead of the official rebalancing on June 26, putting several healthca...

5 Healthcare Stocks Set to Join the Russell 3000

In a report released today, from J.P. Morgan reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released today, B...

Genuit Group (GEN) Receives a Buy from J.P. Morgan

In a report released today, from Deutsche Bank reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released today,...

Genuit Group (GEN) Gets a Buy from Deutsche Bank

In a report released today, from Berenberg Bank reiterated a Buy rating on Genuit Group, with a price target of p440.00. In a report released on Ma...

Genuit Group (GEN) Gets a Buy from Berenberg Bank

G5 Entertainment AB ( ($SE:G5EN) ) has issued an announcement. G5 Entertainment AB has issued a corrected notice for its Annual General Meeting sch...

G5 Entertainment Corrects AGM Notice, Restores CEO Share Allocation Level

Stifel Nicolaus analyst Justin Keywood reiterated a Buy rating on NervGen Pharma on May 21 and set a price target of $6.00. Keywood covers the Heal...

NervGen Pharma (NGEN) Receives a Buy from Stifel Nicolaus

In a report released on May 22, Priyal Woolf from Jefferies maintained a Buy rating on Genuit Group, with a price target of p388.00. The company’s ...

Jefferies Keeps Their Buy Rating on Genuit Group (GEN)

J.P. Morgan analyst maintained a Buy rating on Genuit Group on May 22 and set a price target of p440.00. The company’s shares closed last Friday at...

Genuit Group (GEN) Gets a Buy from J.P. Morgan

Peel Hunt analyst Sam Cullen maintained a Buy rating on Genuit Group on May 22 and set a price target of p360.00. The company’s shares closed last ...

Genuit Group (GEN) Gets a Buy from Peel Hunt

Gen Digital Inc. (GEN) has disclosed a new risk, in the Technology category. Gen Digital Inc. faces rising risk as it embeds AI and generative AI a...

Gen Digital’s AI Ambitions Face Mounting Legal, Regulatory and Cost Risks

Qiagen ( ($QGEN) ) has issued an announcement. Qiagen has disclosed a change in its shareholder structure after the Dutch financial regulator AFM n...

Norges Bank Discloses 3.07% Stake in Qiagen

Qiagen ( ($QGEN) ) has issued an update. QIAGEN has disclosed that the Dutch financial regulator AFM notified the company of a substantial sharehol...

BlackRock Discloses Significant Stake in Qiagen

Qiagen ( ($QGEN) ) has provided an update. The Netherlands Authority for the Financial Markets has notified Qiagen N.V. that UBS Group AG has repor...

UBS Group Discloses 2.87% Voting Stake in Qiagen

Qiagen ( ($QGEN) ) has provided an announcement. Qiagen has disclosed that the Dutch financial markets regulator AFM notified the company of a subs...

Qiagen discloses UBS’s 3.15% stake following AFM notification

NervGen Pharma ( ($NGEN) ) has shared an announcement. On May 21, 2026, NervGen Pharma announced it had commenced an underwritten public offering o...

NervGen Pharma Launches Underwritten Public Offering to Fund NVG-291 Development

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Amkor (AMKR) and Gen Digital (GEN) with bullish sent...

Analysts Offer Insights on Technology Companies: Amkor (AMKR) and Gen Digital (GEN)

Genuit Group ( ($GB:GEN) ) just unveiled an update. Genuit Group plc said all resolutions at its 22 May annual general meeting in Leeds were approv...

Genuit shareholders back all AGM resolutions and approve 8.7p dividend

Genuit Group ( ($GB:GEN) ) has shared an announcement. Genuit Group reported that group revenue for the four months to 30 April 2026 was broadly fl...

Genuit holds revenue steady amid cost pressures and eyes structural growth

Legal & General ( ($GB:LGEN) ) has provided an update. Legal & General shareholders approved all resolutions at the company’s Annual General Meetin...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GEN	$24.18	+1.07%	18.85M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GEN	$24.18	+1.1%	18.85M
3
4
5
6

GEN

GEN

No Data Available

Get Gen Digital Inc. Data in Excel

Get Gen Digital Inc. Data in Excel